What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
Saul N. Faust mainly investigates Internal medicine, Immunology, Vaccination, Randomized controlled trial and Rate ratio.
His study in Internal medicine focuses on Interim analysis in particular.
His studies in Immunology integrate themes in fields like Pneumococcal conjugate vaccine, Meningococcal disease and Virology.
Saul N. Faust interconnects Adverse effect and Reactogenicity, Immunogenicity in the investigation of issues within Vaccination.
He focuses mostly in the field of Randomized controlled trial, narrowing it down to matters related to Odds ratio and, in some cases, Surgery and Meningococcal vaccine.
His work deals with themes such as Relative risk, Lung injury and Mechanical ventilation, which intersect with Rate ratio.
His most cited work include:
- Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
What are the main themes of his work throughout his whole career to date?
Saul N. Faust focuses on Immunology, Internal medicine, Vaccination, Pediatrics and Microbiology.
His research in Immunology intersects with topics in Meningococcal disease, Haemophilus influenzae and Virology.
His study in Internal medicine focuses on Randomized controlled trial, Rate ratio, Mechanical ventilation, Confidence interval and Clinical trial.
His study in Vaccination is interdisciplinary in nature, drawing from both Titer, Booster dose, Carriage, Meningococcal vaccine and Reactogenicity.
Saul N. Faust works mostly in the field of Pediatrics, limiting it down to topics relating to Disease and, in certain cases, Epidemiology.
His work in Microbiology tackles topics such as Biofilm which are related to areas like Antibiotics, Cystic fibrosis, Cephalosporin and Prodrug.
He most often published in these fields:
- Immunology (40.62%)
- Internal medicine (23.26%)
- Vaccination (22.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (23.26%)
- Randomized controlled trial (12.85%)
- Vaccination (22.22%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Randomized controlled trial, Vaccination, Mechanical ventilation and Clinical trial.
His research combines Vaccine efficacy and Internal medicine.
His Randomized controlled trial study combines topics in areas such as Odds ratio, Incidence, MEDLINE and Emergency medicine.
His Vaccination study integrates concerns from other disciplines, such as Carriage, Booster dose, Regimen and Immunogenicity.
His research integrates issues of Rate ratio and Respiratory failure in his study of Mechanical ventilation.
His work carried out in the field of Respiratory failure brings together such families of science as Lung injury, Randomization and Dexamethasone.
Between 2018 and 2021, his most popular works were:
- Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Saul N. Faust mainly focuses on Internal medicine, Mechanical ventilation, Randomized controlled trial, Vaccine efficacy and Rate ratio.
His work in Internal medicine covers topics such as Booster dose which are related to areas like Clinical endpoint.
His study explores the link between Mechanical ventilation and topics such as Respiratory failure that cross with problems in Randomization, Dexamethasone, Lung injury, Emergency medicine and Intensive care.
His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Disease management, Disease and Intensive care medicine.
In Vaccine efficacy, Saul N. Faust works on issues like Clinical trial, which are connected to Cohort and Clinical research.
His Vaccination research includes elements of Reactogenicity and Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
